174
Views
11
CrossRef citations to date
0
Altmetric
Inflammatory Bowel Disease

Alterations of peripheral blood CD5+ B cells in inflammatory bowel disease

, , PhD , MD, , , , , , , & show all
Pages 172-179 | Received 15 May 2008, Published online: 08 Jul 2009

References

  • Hibi T, Ogata H. Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol 2006; 41: 10–6
  • Sands BE. Inflammatory bowel disease: past, present, and future. J Gastroenterol 2007; 42: 16–25
  • Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3: 521–33
  • Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005; 307: 1920–5
  • Rogler G. Update in inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol 2004; 20: 311–7
  • Leon F, Smythies LE, Smith PD, Kelsall BL. Involvement of dendritic cells in the pathogenesis of inflammatory bowel disease. Adv Exp Med Biol 2006; 579: 117–32
  • Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427–34
  • Ince MN, Elliott DE. Immunologic and molecular mechanisms in inflammatory bowel disease. Surg Clin North Am 2007; 87: 681–96
  • Berland R, Wortis HH. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 2002; 20: 253–300
  • Wang H, Clarke SH. Regulation of B-cell development by antibody specificity. Curr Opin Immunol 2004; 16: 246–50
  • Marcos MA, Gaspar ML, Malenchere E, Coutinho A. Isolation of peritoneal precursors of B-1 cells in the adult mouse. Eur J Immunol 1994; 24: 1033–40
  • Dono M, Cerruti G, Zupo S. The CD5+ B-cell. Int J Biochem Cell Biol 2004; 36: 2105–11
  • Dorshkind K, Montecino-Rodriguez E. Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential. Nat Rev Immunol 2007; 7: 213–9
  • Casola S. Control of peripheral B-cell development. Curr Opin Immunol 2007; 19: 143–9
  • Hardy RR. B-1 B cell development. J Immunol 2006; 177: 2749–54
  • Hardy RR. B-1 B cells: development, selection, natural autoantibody and leukemia. Curr Opin Immunol 2006; 18: 547–55
  • Kantor AB. The development and repertoire of B-1 cells (CD5 B cells). Immunol Today 1991; 12: 389–91
  • Baumgarth N, Tung JW, Herzenberg LA. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immunopathol 2005; 26: 347–62
  • Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000; 288: 2222–6
  • Youinou P, Renaudineau Y. The paradox of CD5-expressing B cells in systemic lupus erythematosus. Autoimmun Rev 2007; 7: 149–54
  • Böhm I. Increased peripheral blood B cells expressing the CD5 molecules in association to autoantibodies in patients with lupus erythematosus and evidence to selectively down-modulate them. Biomed Pharmacother 2004; 58: 338–43
  • Renaudineau Y, Pers JO, Bendaoud B, Jamin C, Youinou P. Dysfunctional B cells in systemic lupus erythematosus. Autoimmun Rev 2004; 3: 516–23
  • Le Pottier L, Devauchelle V, Pers JO, Jamin C, Youinou P. The mosaic of B-cell subsets (with special emphasis on primary Sjögren's syndrome). Autoimmun Rev 2007; 6: 149–54
  • Pers JO, Jamin C, Predine-Hug F, Lydyard P, Youinou P. The role of CD5-expressing B cells in health and disease [review]. Int J Mol Med 1999; 3: 239–45
  • Hassan J, Yanni G, Hegarty V, Feighery C, Bresnihan B, Whelan A. Increased numbers of CD5+ B cells and T cell receptor (TCR) gamma delta+ T cells are associated with younger age of onset in rheumatoid arthritis (RA). Clin Exp Immunol 1996; 103: 353–6
  • Xu H, Geddes R, Roberts-Thomson PJ. Low molecular weight IgM and CD5 B lymphocytes in rheumatoid arthritis. Ann Rheum Dis 1994; 53: 383–90
  • Jones BM, Cheng IK, Wong RW, Kung AW. CD5-positive and CD5-negative rheumatoid factor-secreting B cells in IgA nephropathy, rheumatoid arthritis and Graves’ disease. Scand J Immunol 1993; 38: 575–80
  • Shibolet O, Podolsky DK. TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1469–73
  • Rakoff-Nahoum S, Medzhitov R. Role of the innate immune system and host-commensal mutualism. Curr Top Microbiol Immunol 2006; 308: 1–18
  • Ishihara S, Rumi MA, Ortega-Cava CF, Kazumori H, Kadowaki Y, Ishimura N, et al. Therapeutic targeting of Toll-like receptors in gastrointestinal inflammation. Curr Pharm Des 2006; 12: 4215–28
  • Ortega-Cava CF, Ishihara S, Rumi MA, Kawashima K, Ishimura N, Kazumori H, et al. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J Immunol 2003; 170: 3977–85
  • Ortega-Cava CF, Ishihara S, Rumi MA, Aziz MM, Kazumori H, Yuki T, et al. Epithelial Toll-like receptor 5 is constitutively localized in the mouse cecum and exhibits distinctive down-regulation during experimental colitis. Clin Vaccine Immunol 2006; 13: 132–8
  • Wen Z, Fiocchi C. Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis?. Clin Dev Immunol 2004; 11: 195–204
  • Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol 2006; 176: 705–10
  • Mizoguchi E, Mizoguchi A, Preffer FI, Bhan AK. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol 2000; 12: 597–605
  • Onuma EK, Amenta PS, Ramaswamy K, Lin JJ, Das KM. Autoimmunity in ulcerative colitis (UC): a predominant colonic mucosal B cell response against human tropomyosin isoform 5. Clin Exp Immunol 2000; 121: 466–71
  • Yacyshyn BR, Pilarski LM. Expression of CD45RO on circulating CD19+ B cells in Crohn's disease. Gut 1993; 34: 1698–704
  • Veneri D, Franchini M, Vella A, Tridente G, Semenzato G, Pizzolo G, et al. Changes of human B and B-1a peripheral blood lymphocytes with age. Hematology 2007; 12: 337–41
  • Polese L, De Franchis G, Scarpa M, Sturniolo GC, Ruffolo C, Norberto L, et al. B1a lymphocytes in ulcerative colitis. Int J Colorectal Dis 2007; 22: 1005–11
  • Neil GA, Summers RW, Cheyne BA, Capenter C, Huang WL, Kansas GS, et al. CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease. Dig Dis Sci 1992; 37: 1390–5
  • Distelhorst CW. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 2002; 9: 6–19
  • Buttgereit F, Wehling M, Burmester GR. A new hypothesis of modular glucocorticoid actions: steroid treatment of rheumatic diseases revisited. Arthritis Rheum 1998; 41: 761–7
  • Pitzalis C, Pipitone N, Perretti M. Regulation of leukocyte-endothelial interactions by glucocorticoids. Ann N Y Acad Sci 2002; 966: 108–18
  • Scudeletti M, Lanza L, Monaco E, Monetti M, Puppo F, Filaci G, et al. Immune regulatory properties of corticosteroids: prednisone induces apoptosis of human T lymphocytes following the CD3 down-regulation. Ann N Y Acad Sci 1999; 876: 164–79

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.